Thomas Michael Raffay MD FAAP
Neonatal Respiratory Failure & Lung Development
Neonatologist at Rainbow Babies and Children's Hospital/Case Western Reserve University
Join to View Full Profile
11100 Euclid AveRbc Suite 3100Cleveland, OH 44106
Phone+1 216-844-3387
Fax+1 216-844-3380
Dr. Raffay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Neonatal-Perinatal Medicine, 2010 - 2013
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Ohio State University College of MedicineClass of 2007
Certifications & Licensure
OH State Medical License 2007 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Publications & Presentations
PubMed
- S-nitrosylation of pVHL regulates βadrenergic receptor function.Zachary W Grimmett, Hiroki Hayashi, Thomas M Raffay, Justin Lin, Richard T Premont
Proceedings of the National Academy of Sciences of the United States of America. 2025-09-16 - EBNEO Commentary: Late Permissive Hypercapnia for Mechanically Ventilated Preterm Infants.Thomas M Raffay, Rita M Ryan
Acta Paediatrica. 2025-09-15 - Bedside Technologies to Challenge Traditional Rib Counting in Neonatal Respiratory Care.Thomas M Raffay, Charles C Roehr, Richard J Martin
JAMA Pediatrics. 2025-09-01
Press Mentions
EBNEO Commentary: Late Permissive Hypercapnia for Mechanically Ventilated Preterm InfantsSeptember 3rd, 2025- X-ray Rib Counting Unreliable for Neonates' Lung Volume?July 21st, 2025
- Pulmonary Hypertension Linked to Worse Bronchopulmonary Dysplasia Outcomes in InfantsNovember 16th, 2023
Grant Support
- S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lungCASE WESTERN RESERVE UNIVERSITY2024–2028
- S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lungCASE WESTERN RESERVE UNIVERSITY2024–2028
- R01 S-Nitrosoglutathione Reductase in Neonatal Hyperoxic Lung InjuryNIH NHLBI2024–2028
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- R03 GSNO Metabolism in Tracheal AspiratesNIH NHLBI2021–2024
- K08 S-Nitrosoglutathione in BPDNIH NHLBI2017–2023
- U01 PreVENTNIH NHLBI2016–2021
- S-Nitrosoglutathione Reductase Inhibition in PAHATS Foundation Research Award2017–2019
Professional Memberships
- Fellow
- Member
- Society for Pediatric Research - SPRMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
